5 amino 1mq safety Peptide Therapy Selective and membrane-permeable small molecule

Up to 1520% of adults have low or borderline B12 levels , and deficiency is a known cause of neuropathy

Benefits outlined on AgelessRx.com are based on 3rd party studies

Effects on cognition and global function were evaluated with the Alzheimers Disease Assessment Scale Cognitive Subscale (ADAS-Cog) and the Clinician Interview-Based Impression of Change with Caregiver Input scale (CIBIC+) at 4, 12, and 24 weeks after the start of injections

A thicker needle is necessary for IM injections to penetrate the muscle tissue effectively

Serum vitamin B12 was determined at four and six months after the start of treatment

Those with nerve problems might need more B12 to feel better